InsidersTradesSigma
Discover the detailed record of transactions filed by Albanna Rowena, Chief Executive Officer. Officer active across 1 companies, notably Aditx Therapeutics, Inc.. In total, 4 filings have been recorded. Total volume traded: €2k. The latest transaction was filed on 4 June 2021 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations
Rowena Albanna is the Chief Operating Officer at Aditx Therapeutics, Inc. She is responsible for the daily operations of the company and the implementation of operational strategies. Her experience in the biopharmaceutical sector enables her to effectively lead growth initiatives.